While TCM use is in an increasing trend in this country ( Siti et al., 2009 ; Abdullah et al., 2018 ), the low number of TCM reported among our study population may reflect underreporting, which limits the ability to detect an association between TCM use and antihypertensive-associated ADRs.
← all excerpts
Adverse Drug Reactions of Antihypertensives and <i>CYP3A5*3</i> Polymorphism Among Chronic Kidney Disease Patients.
1
—
—